207 related articles for article (PubMed ID: 8010595)
1. What is primary and what secondary for amyloid deposition in Alzheimer's disease.
Meier-Ruge W; Iwangoff P; Bertoni-Freddari C
Ann N Y Acad Sci; 1994 May; 719():230-7. PubMed ID: 8010595
[TBL] [Abstract][Full Text] [Related]
2. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease.
Meier-Ruge W; Bertoni-Freddari C; Iwangoff P
Gerontology; 1994; 40(5):246-52. PubMed ID: 7959080
[TBL] [Abstract][Full Text] [Related]
3. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
4. [Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease].
Mal'tsev AV; Davidchenko NV; Uteshev VK; Sokolik VV; Shtang OM; Iakushun MA; Sokolova NM; Suprin AK; Galzitskaia OV
Biomed Khim; 2013; 59(2):144-70. PubMed ID: 23789343
[TBL] [Abstract][Full Text] [Related]
5. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
6. Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis.
Mueggler T; Meyer-Luehmann M; Rausch M; Staufenbiel M; Jucker M; Rudin M
Eur J Neurosci; 2004 Aug; 20(3):811-7. PubMed ID: 15255991
[TBL] [Abstract][Full Text] [Related]
7. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities.
Blass JP
Neurobiol Aging; 2002; 23(6):1077-84. PubMed ID: 12470805
[TBL] [Abstract][Full Text] [Related]
9. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
[TBL] [Abstract][Full Text] [Related]
10. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
12. Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.
Cheng X; Wu J; Geng M; Xiong J
Neurobiol Aging; 2014 Jun; 35(6):1217-32. PubMed ID: 24368087
[TBL] [Abstract][Full Text] [Related]
13. [Alzheimer disease. Role of beta A4 peptide and cerebral amyloid substance].
Duyckaerts C; Delaère P; He Y; Seilhean D; Hauw JJ
Presse Med; 1994 May; 23(18):848-54. PubMed ID: 7937606
[TBL] [Abstract][Full Text] [Related]
14. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of cerebral amyloid angiopathy: use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer's disease amyloid precursor.
Vinters HV; Pardridge WM; Yang J
Hum Pathol; 1988 Feb; 19(2):214-22. PubMed ID: 3277908
[TBL] [Abstract][Full Text] [Related]
16. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
17. Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses.
Koudinova NV; Berezov TT; Koudinov AR
Biochemistry (Mosc); 1999 Jul; 64(7):752-7. PubMed ID: 10424897
[TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid protein in Alzheimer's disease.
Nalbantoglu J
Can J Neurol Sci; 1991 Aug; 18(3 Suppl):424-7. PubMed ID: 1933692
[TBL] [Abstract][Full Text] [Related]
19. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-antichymotrypsin in brain aging and disease.
Abraham CR; Potter H
Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
